🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Ishwaria M. Subbiah

Sarah Cannon Research Institute

ORCID: 0000-0002-0758-7911

Also affiliated with Peter MacCallum Cancer Centre, Sarah Cannon, Tennessee Oncology, The US Oncology Network, Monash University

Biochemistry, Genetics and Molecular BiologyEconomics, Econometrics and FinanceMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 7%percentile
0.104Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Predicting 180-day mortality for women with ovarian cancer using machine learning and patient-reported outcome data.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.e13555
Top 78%
0.104DataRank
Top 78%1 citations

Charlotte C. Sun, Cai Xu, Amy Schneider, Sheng-Chieh Lu, Ishwaria M. Subbiah +3 more

Papers

Driven by 12 papers — median percentile 22. Top paper: “Trial Sponsorship and Time to Reporting for Phase 3 Randomized Cancer Clinical Trials”.

Trial Sponsorship and Time to Reporting for Phase 3 Randomized Cancer Clinical Trials

Cancers(2020)10.3390/cancers12092636
N/A
0.292DataRank · unranked
6 citations

Clifton D. Fuller, Vivek Verma, W. Ian P. Mainwaring, Andres F. Espinoza, Austin B. Miller +10 more

Everolimus in combination with vandetanib in children, adolescents, and young adults: a phase I study

ESMO Open(2023)10.1016/j.esmoop.2023.101609
N/A
0.256DataRank · unranked
3 citations

X. Wang, Najat C. Daw, C.E. Herzog, Ishwaria M. Subbiah, Wafik Zaky +10 more

Predicting 180-day mortality for women with ovarian cancer using machine learning and patient-reported outcome data.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.e13555
Top 78%
0.104DataRank
Top 78%1 citations

Charlotte C. Sun, Cai Xu, Amy Schneider, Sheng-Chieh Lu, Ishwaria M. Subbiah +3 more

Current update on gallbladder carcinoma

Abdominal Radiology(2021)10.1007/s00261-020-02871-2
N/A
0DataRank · unranked
45 citations

Avinash Kambadakone, Paul Nikolaidis, Vivek Subbiah, Ishwaria M. Subbiah, Catherine Devine +1 more

Safety and activity of vandetanib in combination with everolimus in patients with advanced solid tumors: a phase I study

ESMO Open(2021)10.1016/j.esmoop.2021.100079
N/A
0DataRank · unranked
13 citations

Ruth Sacks, Ishwaria M. Subbiah, Neele Drobnitzky, Sarina A. Piha‐Paul, David S. Hong +15 more

Advances in cancer research dissemination through the pandemic and beyond

Annals of Oncology(2021)10.1016/j.annonc.2021.02.013
N/A
0DataRank · unranked
0 citations

Ishwaria M. Subbiah, Vivek Subbiah, Aakash Desai

The Evolution of Geriatric Oncology and Geriatric Assessment over the Past Decade

Seminars in Radiation Oncology(2022)10.1016/j.semradonc.2021.11.002
N/A
0DataRank · unranked
28 citations

Maya Abdallah, Luiz A. Gil-Jr, Smith Giri, Tina Hsu, Jessica L. Krok‐Schoen +7 more

Long COVID in Cancer patients: Preponderance of Symptoms in Majority of Patients over Long Time Period

medRxiv(2022)10.1101/2022.07.13.22277579
N/A
0DataRank · unranked
1 citations

Anne‐Marie Chaftari, Ishwaria M. Subbiah, Alexandre Malek, Ying Jiang, Peter Lamie +14 more

Long COVID in cancer patients: preponderance of symptoms in majority of patients over long time period

eLife(2023)10.7554/elife.81182
N/A
0DataRank · unranked
42 citations

Anne‐Marie Chaftari, Ishwaria M. Subbiah, Alexandre Malek, Ying Jiang, Peter Lamie +15 more

Development and validation of a patient‐reported outcome measure to assess symptom burden after chimeric antigen receptor T‐cell therapy

British Journal of Haematology(2023)10.1111/bjh.18677
N/A
0DataRank · unranked
18 citations

Samer A. Srour, Tito R. Mendoza, Meagan Whisenant, Ishwaria M. Subbiah, Elizabeth M. Gonzalez +9 more

Patient-Reported Symptom and Functioning Status during the First 12 Months after Chimeric Antigen Receptor T Cell Therapy for Hematologic Malignancies

Transplantation and Cellular Therapy(2021)10.1016/j.jtct.2021.07.007
N/A
0DataRank · unranked
61 citations

Samer A. Srour, Meagan Whisenant, Ishwaria M. Subbiah, Tsun Hsuan Chen, Darcy Ponce +10 more

COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials

Nature Reviews Clinical Oncology(2021)10.1038/s41571-021-00487-z
N/A
0DataRank · unranked
140 citations

Justin F. Gainor, Aparna Hegde, Alison M. Schram, Giuseppe Curigliano, Sumanta K. Pal +19 more